Company Filing History:
Years Active: 1995-2022
Title: L David Sibley: Innovator in Parasitic Infection Treatment
Introduction
L David Sibley is a notable inventor based in University City, MO (US). He has made significant contributions to the field of pharmaceutical preparations, particularly in the treatment of parasitic infections. With a total of 2 patents, Sibley's work has the potential to impact public health significantly.
Latest Patents
Sibley's latest patents include innovative solutions for combating parasitic infections. One of his patents focuses on CDPK1 inhibitors, which are designed to inhibit calcium-dependent protein kinase 1 (CDPK1). This invention relates to pharmaceutical preparations that can be used in the treatment of various parasitic infections. Another patent involves a composition and method for distinguishing between virulent and non-virulent strains of pathogens. This diagnostic assay is based on the discovery of dimorphism in the p30 antigen and gene, which is directly associated with a bimodal virulence pattern. The assays developed can differentiate between virulent (type I) and avirulent (type II) p30 antigens, providing critical insights for effective diagnosis and treatment.
Career Highlights
Throughout his career, Sibley has worked with prestigious institutions, including Leland Stanford Junior University and Vyera Pharmaceuticals, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Sibley has collaborated with notable individuals in his field, including Roland Buelow and John Charles Boothroyd. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
L David Sibley is a prominent inventor whose work in the field of parasitic infection treatment showcases his dedication to advancing medical science. His innovative patents and collaborations highlight the importance of research and development in addressing public health challenges.